Skip to main content

Peer Review reports

From: Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

Original Submission
4 Jul 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
27 Feb 2015 Editorially accepted
14 Mar 2015 Article published 10.1186/s12885-015-1143-y

You can find further information about peer review here.

Back to article page